Design of Novel Aminopyrrolidine Factor Xa Inhibitors from a Screening Hit.
Zbinden, K.G., Anselm, L., Banner, D.W., Benz, J.M., Blasco, F., Decoret, G., Himber, J., Kuhn, B., Panday, N., Ricklin, F., Risch, P., Schlatter, D., Stahl, M., Thomi, S., Unger, R., Haap, W.(2009) Eur J Med Chem 44: 2787
- PubMed: 19200624 
- DOI: https://doi.org/10.1016/j.ejmech.2008.12.025
- Primary Citation of Related Structures:  
2VVC, 2VVU, 2VVV, 2VWL, 2VWM, 2VWN, 2VWO - PubMed Abstract: 
Starting from a hit identified by focused screening, 3-aminopyrrolidine factor Xa inhibitors were designed. The binding mode as determined by X-ray structural analysis as well as the pharmacokinetic behaviour of selected compounds is discussed.
Organizational Affiliation: 
F Hoffmann - La Roche Ltd, Basel, Switzerland. katrin.groebke_zbinden@roche.com